Search for: "SHIRE V SANDOZ"
Results 1 - 20
of 39
Sort by Relevance
|
Sort by Date
17 May 2021, 12:45 am
On the 20th of August 2013 AstraZeneca served the decision on Sandoz, thereby forcing Sandoz off the market. [read post]
4 Jun 2015, 2:03 am
Sandoz in affirming ED Texas in Fenner v. [read post]
3 Jun 2015, 9:23 pm
Shire v. [read post]
28 Jan 2015, 10:00 pm
On January 26, 2015, the Supreme Court granted certiorari, vacated, and remanded Shire Development LLC v. [read post]
26 Jan 2015, 10:37 am
Butamax, and Shire v. [read post]
9 Apr 2014, 9:59 pm
The problems with the current jurisprudential situation regarding claim construction are nicely illustrated by the Court's decision in Shire Development, LLC v. [read post]
15 Jan 2012, 8:27 pm
Shire LLC et al. v. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine… [read post]
2 Jun 2011, 12:46 pm
Nail v. [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
11 May 2011, 4:54 am
Highlights this week included: US: Federal Trade Commission issues report on reverse settlement agreements in FY2010 (Patent Docs) (Orange Book Blog) (FDA Law Blog) US: Billups-Rothenberg v. [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification… [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
4 Aug 2010, 12:21 am
(FDA Law Blog) Aricept (Donepezil) – US: Teva agrees to dismiss suit with Eisai over Aricept patent (Patent Docs) Carbatrol (Carbamazepine) – US: Patent infringement complaint following a Paragraph IV certification: Shire LLC v. [read post]
14 Jul 2010, 6:47 pm
(Patent Docs) NovoNorm (Repaglinide) – France: Tribunal de Grande Instance: Claims 2 and 3 invalid for lack of novelty: Hexal and Sandoz v. [read post]
10 Jun 2010, 3:58 am
(SmartBrief) Emend (Aprepitant) - US: Sandoz counterclaims for two patents dismissed in Merck’s Emend suit (Patent Docs) Intuniv (Guanfacine) – US: Patent infringement complaint based on ANDA filing: Shire LLC et al. v. [read post]
27 May 2010, 3:20 am
Sandoz Inc. [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed – US: Monsanto files patent infringement suit based on defendant’s use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
